We found that SIRT1 serum levels statistically significantly differ between MS patients and control group subjects (1.833 (2.488) ng/mL vs. 0.094 (0.038) ng/mL, p < 0.001) (Figure 1). Here, SIRT1 is linked to myeloid sarcoma.